Class 009: Downloadable electronic publications, namely, newsletters, speaker communications, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and reproductions in relation to information and storytelling in the field of pharmaceutical and cardiovascular disease; Class 016: printed educational materials in the field of pharmaceutical and cardiovascular disease; Class 018: backpacks; Class 021: mugs; water bottles sold empty; Class 025: Clothing, namely, sweatshirts, shirts, hats, and jackets; Class 041: Education services, namely, providing webinars, seminars, and conferences in the field pharmaceutical and cardiovascular disease; Class 042: Information services relating to pharmaceutical and cardiovascular disease; providing a website relating to pharmaceutical and cardiovascular disease; non-downloadable electronic publications distributed online, namely, newsletters, speaker communications, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and reproductions in relation to information and storytelling in the field of pharmaceutical and cardiovascular disease
Class 009: Downloadable electronic publications, namely, newsletters, speaker communications, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and reproductions in relation to information and storytelling in the field of pharmaceutical and cardiovascular disease; Class 016: printed educational materials in the field of pharmaceutical and cardiovascular disease; Class 018: backpacks; Class 021: mugs; water bottles sold empty; Class 025: Clothing, namely, sweatshirts, shirts, hats, and jackets; Class 041: Education services, namely, providing webinars, seminars, and conferences in the field pharmaceutical and cardiovascular disease; Class 042: Information services relating to pharmaceutical and cardiovascular disease; providing a website relating to pharmaceutical and cardiovascular disease; non-downloadable electronic publications distributed online, namely, newsletters, speaker communications, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and reproductions in relation to information and storytelling in the field of pharmaceutical and cardiovascular disease
Class 016: Printed educational materials in the field of pharmaceutical and cardiovascular disease; Class 035: Medical billing support services; Financial record-keeping for medical patients; Class 036: Providing insurance information; Insurance administration services, namely,assisting others with collecting insurance premiums; Insurance administrationservices, namely, assisting others with adjusting insurance claims; Financialadministration of medication reimbursement programs and services; Financialadministration of health reimbursement arrangements; Class 041: Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of cardiovascular disease; Class 044: Medical advisory services; Medical services in the field of cardiovascular conditions and pharmaceuticals
Class 005: pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of cardiovascular disease; Printed educational materials in the field of pharmaceutical and cardiovascular disease; Providing insurance information; Insurance administration services, namely, assisting others with collecting insurance premiums; Insurance administration services, namely, assisting others with adjusting insurance claims; Financial administration of medication reimbursement programs and services; Financial administration of health reimbursement arrangements; Medical billing support services; Financial record-keeping for medical patients; Medical advisory services; Medical services in the field of cardiovascular conditions and pharmaceuticals
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Education services, namely, providing webinars, seminars, and conferences in the field of hypertrophic cardiomyopathy (HCM); Providing classes to caregivers and patients regarding treatments and support for hypertrophic cardiomyopathy (HCM); non- downloadable electronic publications distributed online, namely, newsletters, speaker communications in the nature of articles, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and graphic art reproductions in relation to information and storytelling about hypertrophic cardiomyopathy (HCM) and patient support programs; Downloadable electronic publications, namely, newsletters, speaker communications in the nature of downloadable written articles, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and graphic art reproductions in relation to information and storytelling about hypertrophic cardiomyopathy (HCM) and patient support programs; Printed materials, namely, newsletters, speaker communications in the nature of printed articles, magazines, catalogues, posters, flyers, brochures, pamphlets, graphical prints, graphical presentations, and framed graphic art reproductions in relation to information and storytelling about hypertrophic cardiomyopathy (HCM) and patient support programs; Printed materials, namely, display banners of cardboard in relation to information and storytelling about hypertrophic cardiomyopathy (HCM) and patient support programs; Health care services, namely, providing information about medical experiences to physicians, health care professionals and patients on the topic of hypertrophic cardiomyopathy (HCM); Providing patient support in the nature of medical information about hypertrophic cardiomyopathy (HCM); Providing information relating to hypertrophic cardiomyopathy (HCM) medical treatment; providing a website containing information relating to hypertrophic cardiomyopathy (HCM) medical treatment; providing medical information about hypertrophic cardiomyopathy (HCM) and medical treatment patient support programs through videos; Providing information about medical research in the field of hypertrophic cardiomyopathy (HCM) medical treatment; Graphic design of advertising banners in relation hypertrophic cardiomyopathy (HCM) and patient support programs; providing a website containing information relating to hypertrophic cardiomyopathy (HCM) medical research
Education services, namely, providing non-downloadable webinars, seminars, and conducting conferences in the field of hypertrophic cardiomyopathy (HCM); providing classes to caregivers and patients regarding treatments and support for hypertrophic cardiomyopathy (HCM); non-downloadable electronic publications distributed online, namely, newsletters in the field of hypertrophic cardiomyopathy (HCM), speaker communications in the nature of articles in the field of hypertrophic cardiomyopathy (HCM), magazines in the field of hypertrophic cardiomyopathy (HCM), catalogues in the field of hypertrophic cardiomyopathy (HCM), posters, informational flyers on hypertrophic cardiomyopathy (HCM), brochures in the field of hypertrophic cardiomyopathy (HCM), pamphlets in the field of hypertrophic cardiomyopathy (HCM), printable graphics, graphical presentation materials, and graphical reproductions containing information and stories about hypertrophic cardiomyopathy (HCM) and patient support programs; providing online non-downloadable videos about hypertrophic cardiomyopathy (HCM) and patient support programs; Downloadable electronic publications, namely, newsletters in the field of hypertrophic cardiomyopathy (HCM), speaker communications in the nature of articles in the field of hypertrophic cardiomyopathy (HCM), magazines in the field of hypertrophic cardiomyopathy (HCM), catalogues in the field of hypertrophic cardiomyopathy (HCM), posters, informational flyers on hypertrophic cardiomyopathy (HCM), brochures in the field of hypertrophic cardiomyopathy (HCM), pamphlets in the field of hypertrophic cardiomyopathy (HCM), printable graphics, graphical presentation materials, and graphical reproductions containing information and stories about hypertrophic cardiomyopathy (HCM) and patient support programs; Printed materials, namely, newsletters in the field of hypertrophic cardiomyopathy (HCM), speaker communications in the nature of printed articles in the field of hypertrophic cardiomyopathy (HCM), magazines in the field of hypertrophic cardiomyopathy (HCM), catalogues in the field of hypertrophic cardiomyopathy (HCM), posters, informational flyers on hypertrophic cardiomyopathy (HCM), brochures in the field of hypertrophic cardiomyopathy (HCM), pamphlets in the field of hypertrophic cardiomyopathy (HCM), graphical prints, graphical presentation materials, and graphical reproductions containing information and stories about hypertrophic cardiomyopathy (HCM) and patient support programs; Health care services, namely, providing information to physicians, health care professionals and patients on the topic of hypertrophic cardiomyopathy (HCM); Providing patient healthcare support, namely, providing health information about hypertrophic cardiomyopathy (HCM); providing patient support in the nature of healthcare, namely, providing information about the location of medical treatment facilities; Health information services relating to hypertrophic cardiomyopathy (HCM); providing a website featuring health information relating to hypertrophic cardiomyopathy (HCM); Website providing health information about hypertrophic cardiomyopathy (HCM) and patient support programs; "HCM"; Scientific information services relating to hypertrophic cardiomyopathy (HCM); providing a website featuring scientific information relating to hypertrophic cardiomyopathy (HCM); Website providing scientific information about hypertrophic cardiomyopathy (HCM) and patient support programs
Pharmaceutical preparations for the treatment of cardiovascular, heart and muscle diseases and disorders | Providing information services in the field of cardiovascular, heart and muscle disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of cardiovascular, heart and muscle diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of cardiovascular, heart and muscle diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for cardiovascular, heart and muscle diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular, heart and muscle diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of cardiovascular, heart and muscle disease and conditions; Providing a website featuring educational information in the field of cardiovascular, heart and muscle diseases and conditions
Pharmaceutical preparations for the treatment of cardiovascular, heart and muscle diseases and disorders | Providing information services in the field of cardiovascular, heart and muscle disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of cardiovascular, heart and muscle diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of cardiovascular, heart and muscle diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for cardiovascular, heart and muscle diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular, heart and muscle diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of cardiovascular, heart and muscle disease and conditions; Providing a website featuring educational information in the field of cardiovascular, heart and muscle diseases and conditions
pharmaceutical preparations for human use, namely medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
human pharmaceuticals for the prevention, diagnosis, and treatment of cardiovascular diseases and conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions; Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs; Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease
Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions; Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs; Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease; "PATIENT SUPPORT SERVICES"
pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction
human pharmaceuticals for the treatment of cardiovascular diseases, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness; research in the field of cellular assay screening and pharmaceutical discovery and development
human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions; infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin
human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness
[ Technical consulting and ] research in the field of cellular assay screening and pharmaceutical discovery and development; [ consultation, ] collaboration, and research services relating to drug discovery and development [ ; information services relating to drug discovery and development ]
Human pharmaceuticals for the treatment of neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, or skeletal muscle weakness
[Computer software for use in screening cellular assays; computer software used in the collection analysis, and presentation of medical information in the field of pharmaceutical drug development]; Oncologic, cardiovascular, infectious disease, neurologic, anti-inflammatory and ophthalmological pharmaceuticals
[Computer software for use in screening cellular assays; computer software used in the collection, analysis and presentation of medical, information in the field of pharmaceutical drug development]; Oncologic, cardiovascular, infectious disease, neurologic, anti-inflammatory, and ophthalmological pharmaceuticals
Class 009: Computer software and instrumentation for the analysis and display of cellular analyses; Class 042: Consultation and collaboration services relating to cellular assays for screening, drug discovery, patient diagnosis, and patient therapy
Class 009: Computer software for use in screening cellular assays; computer software used in the collection, analysis, and presentation of medical information in the field of pharmaceutical drug development
automated imaging instruments; software and data analyzers relating to the same; automated sample handling instruments; and software and data analyzers relating to the same
